In our resistant cell lines, EPHA2 was strongly overexpressed, while EFNA1 gene expression levels remained at baseline level, mirroring the previous findings of EPHA2 high and EFNA1 low expression pattern, associated with reduced survival in CRC patients (Robertis et al. 2017). The gene discussed is EFNA1; the disease is colorectal carcinoma.